Brief: Rubius Therapeutics To Present At Society For Immunotherapy Of Cancer's Annual Meeting Preclinical Data From Oncology Program
15/10/2020 14:26
Oct 15 (Reuters) - Rubius Therapeutics Inc RUBY.O :
* RUBIUS THERAPEUTICS ANNOUNCES PRECLINICAL DATA SUPPORTING
ITS
LEAD CLINICAL ONCOLOGY PROGRAM, RTX-240, TO BE PRESENTED AT THE
SOCIETY FOR IMMUNOTHERAPY OF CANCER’S ANNUAL MEETING
Source text for Eikon: ID:nGNX7cBV5M
Further company coverage: RUBY.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rubius Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Apple, TCR2 Therapeutics, Silvergate Capital
Brief: Rubius Therapeutics Inc - Nasdaq Notified Co That Trading In Co's Stock Will Be Suspended Upon Opening Of Business On March 7, 2023
Brief: Rubius Therapeutics Board Of Directors Approved Plan Of Liquidation And Dissolution Of Company
Rubius Therapeutics Inc expected to post a loss of 30 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Baidu, Boeing, Microsoft